Imidazoquinoline derivatives as adenosine A3 receptor ligands

This invention is directed to a compound of formula (I), wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, Z, m, n, o, p and r are as defined herein, its preparation, pharmaceutical composition and use as an adenosine A3 receptor ligand preferably an antagonist.

Saved in:
Bibliographic Details
Main Authors KINGA BOER, MARIA BALOGH, ENDRE MIKUS, KATALIN URBAN-SZABO, ERZSEBET WALCZ, JUDIT VARGANE SZEREDI, LASZLO BALAZS, PETER ARANYI, KATALIN GERBER, ZOLTAN KAPUI, LAJOS T. NAGY, SANDOR BATORI, GEZA TIMARI
Format Patent
LanguageEnglish
Published 14.05.2009
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:This invention is directed to a compound of formula (I), wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, Z, m, n, o, p and r are as defined herein, its preparation, pharmaceutical composition and use as an adenosine A3 receptor ligand preferably an antagonist.
Bibliography:Application Number: AU20030282263